State Ledger
Company profile

Summit Therapeutics Inc. CIK 1599298

Ticker
SMMT (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Miami, FL 33131
Fiscal year end
2025 (FY)
Market Data
Close
$17.15
Change
-$0.44
Change %
-2.50%
Volume
334,621

SMMT · trading date Oct 12, 2026 · previous close $17.59 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$1.08B
Total assets
$751.18M
Total liabilities
$92.32M
Stockholders' equity
$658.86M
Cash & equivalents
$225.27M
Operating income
—
Operating cash flow
-$322.93M
Capital expenditures
$657.0K

Fiscal year 2025, via 10-K filed 2026-02-23. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$323.59M
Free cash flow margin
—
Liabilities / assets
12.3%
Equity / assets
87.7%
CapEx / revenue
—
Operating cash flow / net income
0.30×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$1.08B $751.18M $92.32M $658.86M
2024 $0 -$221.32M $435.56M $46.81M $388.75M
2023 $0 -$614.93M $202.95M $125.26M $77.69M
2022 $705.0K -$78.78M $664.17M $537.51M $126.65M
2021 $1.81M -$88.60M $113.37M $30.09M $83.28M
Company Details
SIC code
2834
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-15
Financials filed via
Form 10-K
filed 2026-02-23

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Miami, FL 33131
601 BRICKELL KEY DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:04 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Florida — Public Companies